Ovid Therapeutics Inc. Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ovid Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Ovid Therapeutics Inc. Operating Margin for the quarter ending September 30, 2024 was -11K %, a 38.9% increase year-over-year.
  • Ovid Therapeutics Inc. annual Operating Margin for 2023 was -15.1K %, a 309% decline from 2022.
  • Ovid Therapeutics Inc. annual Operating Margin for 2022 was -3.7K %, a 6301% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -11K +7K +38.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -12K +15.2K +55.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13K +30.9K +70.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.1K -11.4K -309% Oct 1, 2023 Dec 31, 2023
Q3 2023 -18K Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.2K Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.9K Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.7K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.